Chengdu Qingshan Likang Pharmaceutical Co., Ltd (Qingshan Likang for short) is by Chengdu Likang Industrial Co., Ltd, China Pharmaceutical Group Qingshan Pharmaceutical Factory and Chengdu Medical Plastics Factory, *** with the investment in the establishment. Qingshan Likang is a high-tech enterprise specializing in the production of soft-bag large-capacity injections. The company is built in strict accordance with GMP standards and adopts domestic advanced production equipment, which has a good production environment and technical conditions. Qingshan Likang adheres to the concept of people-oriented medical science and technology, and takes the product service to the society as the purpose, and closely combines the perfect quality management system and rigorous scientific attitude to ensure the first-class product quality. The company's main equipment adopts the products of advanced manufacturers of domestic counterparts, and part of the equipment is imported, which further provides full guarantee for product quality. The fully enclosed soft bag infusion is safer, more reasonable and more convenient than the traditional bottle infusion to meet people's higher level requirements for health care.
The company took the lead in quoting the Europe and the United States PVC high-tech production of soft bags of infusion, is its unique anti-pollution, impact resistance, small size, light weight, easy to operate, cost-effective and high advantages, has been gradually by the major hospitals in the user's favor, and has been widely used to get unanimously praised. May 3, 2012, the company and the Chengdu Qingshan Likang Pharmaceutical Co. Ltd. and its shareholders, Chengdu Likang Industry Co., Ltd. and Chengdu Hangli Science and Technology Group Co., Ltd. signed the Capital Increase Agreement, which stipulates that the company, as a new shareholder, will increase the capital of Qingshan Likang with 206 million yuan. The company intends to use 176 million yuan of oversubscribed funds and 29.537 million yuan of its own funds for this capital increase. The capital increase will be mainly used for the construction of the new GMP project of Qingshan Likang and replenishment of working capital.